These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1936512)

  • 1. Does protease inhibitor inhibit complement activation caused by the immune complex associated with islet cell surface antibody?
    Okada S; Sato K; Ichiki K; Tanokuchi S; Ishii K; Ota Z; Takeda A
    J Int Med Res; 1991; 19(3):234-6. PubMed ID: 1936512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation pathways associated with islet cell surface antibody (ICSA) derived from child patients with insulin-dependent diabetes mellitus (IDDM).
    Okada S; Ichiki K; Sato K; Tanokuchi S; Ishii K; Hamada H; Ota Z
    Acta Med Okayama; 1991 Jun; 45(3):185-6. PubMed ID: 1909828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune islet killing mechanisms associated with insulin-dependent diabetes: three rabbit antibody-mediated islet cell cytotoxicity models.
    Charles MA; Suzuki M; Slater L; Waldeck N; Ong K
    Diabetologia; 1983 Oct; 25(4):348-54. PubMed ID: 6357917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-dependent antibody-mediated cytotoxicity (C'AMC) to pancreatic islet cells in the spontaneously diabetic BB/OK rat: interference from cell-bound and soluble inhibitors.
    Hehmke B; Schröder D; Klöting I; Kohnert KD
    J Clin Lab Immunol; 1991 Jun; 35(2):71-81. PubMed ID: 1668761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum C3 and C4 levels and complement-dependent antibody-mediated cytotoxic activity of islet cell surface antibody in type 1 (insulin-dependent) diabetic children.
    Okada S; Sato K; Miyai Y; Masaki Y; Higuchi T; Ogino Y; Ota Z
    Diabetologia; 1987 Nov; 30(11):869-73. PubMed ID: 3328722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of sera obtained from children with insulin-dependent diabetes mellitus on cultivated islet cells: cytotoxicity and insulin release.
    Sadovnikova NV; Pankov YA; Fedotov VP; Czernushkina AV; Zhukovsky MA; Shcherbacheva LN
    Exp Clin Endocrinol; 1989 May; 93(2-3):166-72. PubMed ID: 2673810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for enhanced rates of complement activation in serum from patients with newly diagnosed insulin-dependent diabetes mellitus exposed to rat islet cells and complement-dependent induction of islet cell apoptosis.
    Caraher EM; Conroy SJ; Newsholme P
    J Endocrinol; 1999 Jul; 162(1):143-53. PubMed ID: 10396031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic.
    Radillo O; Nocera A; Leprini A; Barocci S; Mollnes TE; Pocecco M; Pausa M; Valente U; Betterle C; Tedesco F
    Clin Immunol Immunopathol; 1996 Jun; 79(3):217-23. PubMed ID: 8635278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological events in new onset diabetes.
    Charles M; Suzuki M; Sundsmo J; Waldeck N; Negishi K; Slater L; Ong K; Buckingham B; Kershnar A
    Biomed Biochim Acta; 1984; 43(5):615-9. PubMed ID: 6383365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antithyroid autoantibodies on pancreatic islet-cell function.
    Kitano N; Taminato T; Seno M; Miyamoto Y; Seino Y; Matsukura S; Imura H
    Acta Diabetol Lat; 1987; 24(1):9-15. PubMed ID: 3303784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of serum from diabetes-prone BB/OK rats on neonatal rat pancreatic islets and islet cell suspensions.
    Schröder D; Hehmke B; Klöting I; Besch W
    Exp Clin Endocrinol; 1989 May; 93(2-3):187-92. PubMed ID: 2673813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of islet cell surface antibodies on neonatal rat pancreatic islet cells or isolated islets of Langerhans in vitro.
    Schröder D; Hehmke B; Kohnert KD; Fiebach H; Jenssen HL; Besch W
    Biomed Biochim Acta; 1985; 44(1):107-15. PubMed ID: 3888202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of syngeneic islet antigen administration on complement-dependent antibody-mediated cytotoxicity to islet cells and diabetes onset in diabetes-prone BB/OK rats.
    Schröder D; Schmidt S; Klöting I; Hehmke B
    Autoimmunity; 1993; 14(4):283-9. PubMed ID: 8347771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early appearance of complement-dependent antibody mediated cytotoxicity (C'AMC) to islet cells in serum of diabetes-prone BB/OK rats.
    Hehmke B; Schröder D; Klöting I
    Diabetes Res; 1990 Apr; 13(4):183-6. PubMed ID: 2134210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation via the alternative pathway in a patient with insulin-dependent diabetes mellitus.
    Okada S; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Yamamoto H; Ota Z
    J Int Med Res; 1991; 19(4):348-50. PubMed ID: 1916009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
    Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients.
    Köhler E; Knospe S; Hahn HJ; Roemer KG; Diamantstein T
    Exp Clin Endocrinol; 1989 May; 93(2-3):143-6. PubMed ID: 2673806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.